Defining the role of mTOR in cancer.
摘要:
The mammalian target of rapamycin (mTOR) has emerged as a critical effector in cell-signaling pathways commonly deregulated in human cancers. This has led to the prediction that mTOR inhibitors may be useful in oncology, and derivatives of one such molecule, rapamycin (from which mTOR derives its name), are currently in clinical development. In this review, we discuss recent progress in understanding mTOR signaling, paying particular attention to its relevance in cancer. We further discuss the use of rapamycin in oncology and conclude with a discussion on the future of mTOR-targeted therapy.
展开
关键词:
Humans Protein Kinases Antineoplastic Agents Signal Transduction Neoplasms Phosphatidylinositol 3-Kinases TOR Serine-Threonine Kinases Proto-Oncogene Proteins c-akt
DOI:
10.1016/j.ccr.2007.05.008
被引量:
年份:
2007
























































通过文献互助平台发起求助,成功后即可免费获取论文全文。
相似文献
参考文献
引证文献
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用!